Table of Contents
Targeting multiple conditions is likely to increase a drug’s potential target audience and result in large financial returns for the developing company. With annual sales counted in billions of dollars, these blockbuster drugs are undoubtedly attractive to companies developing generics and biosimilars. The logic is simple: more indications result in a larger number of potential patients and, consequently, greater revenue opportunities. ...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Louis
+1 718 618 4302
STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important ...
TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing ...
... September 2012) why now Office of generic drugs (ogd)/fda has been significantly under resourced for more than a decade the pharmaceutical industry has globalized requiring fda oversight ...
Reportlinker.com © Copyright 2014. All rights reserved.